Plant-based vaccines and cancer therapy: Where are we now and where are we going?

Area of Science:

• Oncology
• Vaccinology
• Biotechnology

Background:

• Therapeutic cancer vaccines represent a significant advancement in treating late-stage cancers.
• The recent FDA approval of the first therapeutic cancer vaccine highlights the field's progress.
• Ongoing clinical trials aim to enhance vaccine efficacy.

Purpose of the Study:

• To review existing therapeutic cancer vaccines.
• To focus on plant-based vaccine systems for cancer therapy.
• To discuss the advantages and challenges of plant-based anti-cancer vaccines.

Main Methods:

• Literature review of therapeutic cancer vaccines.
• Analysis of plant expression systems for vaccine production.
• Summary of pre-clinical and clinical trial data.

Main Results:

• Plant-based systems offer high safety and low-cost recombinant protein synthesis for vaccines.
• Several plant-based vaccine strategies are under investigation.
• Technical obstacles in plant-based vaccine development are being addressed.

Conclusions:

• Plant-based vaccines are a promising avenue for developing novel cancer therapies.
• Further research is needed to overcome current limitations in plant-based vaccine technology.
• The field anticipates improved efficacy and broader application of these vaccines.